AdaptHealth director acquires 13,740 AHCO shares

AdaptHealth Corp. director Theodore B. Lundberg reported acquiring 13,740 shares of AdaptHealth common stock on January 9, 2026.

Rhea-AI Filing Summary

AdaptHealth Corp. director Theodore B. Lundberg reported acquiring 13,740 shares of AdaptHealth common stock on January 9, 2026. The filing shows the shares were received at a price of $0 per share and are described as restricted stock units that will be settled in common stock upon vesting. Following this transaction, Lundberg is shown as beneficially owning 873,496 shares of AdaptHealth common stock with direct ownership.

Insider Trade Summary

Grant/Award: 13,740 shares

Grant/Award 1 txn

Insider Lundberg Theodore B.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,740	$0.00	$0.00

Holdings After Transaction: Common Stock — 873,496 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) report for Theodore B. Lundberg?

The filing reports that director Theodore B. Lundberg acquired 13,740 shares of AdaptHealth common stock on January 9, 2026, coded as an acquisition.

At what price were the 13,740 AdaptHealth (AHCO) shares acquired?

The 13,740 shares of AdaptHealth common stock were reported as acquired at a price of $0 per share.

How many AdaptHealth (AHCO) shares does Theodore B. Lundberg own after this transaction?

After the reported acquisition, Theodore B. Lundberg is shown as beneficially owning 873,496 shares of AdaptHealth common stock.

What type of equity did Theodore B. Lundberg receive from AdaptHealth (AHCO)?

The footnote explains that the reported shares represent restricted stock units that will be settled in common stock upon vesting.

Is Theodore B. Lundberg a director or officer of AdaptHealth (AHCO)?

The filing identifies Theodore B. Lundberg as a director of AdaptHealth Corp. and not as an officer or 10% owner.

Is the AdaptHealth (AHCO) Form 4 filed for one reporting person or a group?

The document states that the Form 4 is filed by one reporting person, namely Theodore B. Lundberg.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/13/2026 - 04:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lundberg Theodore B.

(Last) (First) (Middle)

C/O ADAPTHEALTH CORP.

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		13,740(1)	A	$0	873,496	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Richard Rew, as attorney-in-fact for Theodore B. Lundberg	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.